Experimental murine models of brainstem gliomas

被引：3
作者：
Ni, Shuting [1 ]
Chen, Rujing [1 ,2 ]
Hu, Kaili [1 ]
机构：
[1] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Murad Res Ctr Modernized Chinese Med, Shanghai 201203, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pharm, Shanghai 200025, Peoples R China
来源：
DRUG DISCOVERY TODAY | 2022年 / 27卷 / 05期
关键词：
Experimental murine model; Brainstem glioma; Diffuse intrinsic pontine glioma; INTRINSIC PONTINE GLIOMA; CONVECTION-ENHANCED DELIVERY; PEDIATRIC HIGH-GRADE; MOUSE MODEL; DIFFUSE; CELLS; GLIOBLASTOMA; INHIBITION; CHILDREN; TUMORS;
D O I：
10.1016/j.drudis.2021.12.016
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
As an intractable central nervous system (CNS) tumor, brainstem glioma (BG) is one of the leading causes of pediatric death by brain tumors. Owing to the risk of surgical resection and the little improvement in survival time after radiotherapy and chemotherapy, there is an urgent need to find reliable model systems to better understand the regional pathogenesis of the brainstem and improve treatment strategies. In this review, we outline the evolution of BG murine models, and discuss both their advantages and limitations in drug discovery.
引用
收藏
页码：1218 / 1235
页数：18
相关论文
共 114 条
  • [1] Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma
    Akamandisa, Mwangala Precious
    Nie, Kai
    Nahta, Rita
    Hambardzumyan, Dolores
    Castellino, Robert Craig
    [J]. NEURO-ONCOLOGY, 2019, 21 (06) : 786 - 799
  • [2] Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery
    Alli, Saira
    Figueiredo, Carlyn A.
    Golbourn, Brian
    Sabha, Nesrin
    Wu, Megan Yijun
    Bondoc, Andrew
    Luck, Amanda
    Coluccia, Daniel
    Maslink, Colin
    Smith, Christian
    Wurdak, Heiko
    Hynynen, Kullervo
    O'Reilly, Meaghan
    Rutka, James T.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2018, 281 : 29 - 41
  • [3] Diffuse midline glioma H3 K27M-mutant in adults: A report of six cases and literature review
    Alzoubi, Hiba
    Maraqa, Bayan
    Hasasna, Nabil
    Giangaspero, Felice
    Antonelli, Manila
    Gianno, Francesca
    Arcella, Antonella
    Al-Hussaini, Maysa
    [J]. CLINICAL NEUROPATHOLOGY, 2021, 40 (02) : 108 - 117
  • [4] Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG
    Anastas, Jamie N.
    Zee, Barry M.
    Kalin, Jay H.
    Kim, Mirhee
    Guo, Robyn
    Alexandrescu, Sanda
    Blanco, Mario Andres
    Giera, Stefanie
    Gillespie, Shawn M.
    Das, Jayanta
    Wu, Muzhou
    Nocco, Sarah
    Bonal, Dennis M.
    Quang-De Nguyen
    Suva, Mario L.
    Bernstein, Bradley E.
    Alani, Rhoda
    Golub, Todd R.
    Cole, Philip A.
    Filbin, Mariella G.
    Shi, Yang
    [J]. CANCER CELL, 2019, 36 (05) : 528 - +
  • [5] An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing
    Aoki, Yasuyuki
    Hashizume, Rintaro
    Ozawa, Tomoko
    Banerjee, Anu
    Prados, Michael
    James, C. David
    Gupta, Nalin
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2012, 108 (01) : 29 - 35
  • [6] Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma
    Bailey, Cavan P.
    Figueroa, Mary
    Gangadharan, Achintyan
    Yang, Yanwen
    Romero, Megan M.
    Kennis, Bridget A.
    Yadavilli, Sridevi
    Henry, Verlene
    Collier, Tiara
    Monje, Michelle
    Lee, Dean A.
    Wang, Linghua
    Nazarian, Javad
    Gopalakrishnan, Vidya
    Zaky, Wafik
    Becher, Oren J.
    Chandra, Joya
    [J]. NEURO-ONCOLOGY, 2020, 22 (09) : 1302 - 1314
  • [7] Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas
    Barth, Rolf F.
    Kaur, Balveen
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2009, 94 (03) : 299 - 312
  • [8] PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma
    Barton, Kelly L.
    Misuraca, Katherine
    Cordero, Francisco
    Dobrikova, Elena
    Min, Hooney D.
    Gromeier, Matthias
    Kirsch, David G.
    Becher, Oren J.
    [J]. PLOS ONE, 2013, 8 (10):
  • [9] Preclinical Evaluation of Radiation and Perifosine in a Genetically and Histologically Accurate Model of Brainstem Glioma
    Becher, Oren J.
    Hambardzumyan, Dolores
    Walker, Talia R.
    Helmy, Karim
    Nazarian, Javad
    Albrecht, Steffen
    Hiner, Rebecca L.
    Gall, Sarah
    Huse, Jason T.
    Jabado, Nada
    MacDonald, Tobey J.
    Holland, Eric C.
    [J]. CANCER RESEARCH, 2010, 70 (06) : 2548 - 2557
  • [10] Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
    Bender, Sebastian
    Tang, Yujie
    Lindroth, Anders M.
    Hovestadt, Volker
    Jones, David T. W.
    Kool, Marcel
    Zapatka, Marc
    Northcott, Paul A.
    Sturm, Dominik
    Wang, Wei
    Radlwimmer, Bernhard
    Hojfeldt, Jonas W.
    Truffaux, Nathalene
    Castel, David
    Schubert, Simone
    Ryzhova, Marina
    Seker-Cin, Huriye
    Gronych, Jan
    Johann, Pascal David
    Stark, Sebastian
    Meyer, Jochen
    Milde, Till
    Schuhmann, Martin
    Ebinger, Martin
    Monoranu, Camelia-Maria
    Ponnuswami, Anitha
    Chen, Spenser
    Jones, Chris
    Witt, Olaf
    Collins, V. Peter
    von Deimling, Andreas
    Jabado, Nada
    Puget, Stephanie
    Grill, Jacques
    Helin, Kristian
    Korshunov, Andrey
    Lichter, Peter
    Monje, Michelle
    Plass, Christoph
    Cho, Yoon-Jae
    Pfister, Stefan M.
    [J]. CANCER CELL, 2013, 24 (05) : 660 - 672
12345678910